Castle Biosciences CSTL Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$24.16M-232% | $18.25M+132% | -$57.47M+14.4% | -$67.14M-115% | ||
| $40.77M+155% | $16M+29.7% | $12.33M+16.9% | $10.54M+209% | ||
| $45.89M-8.8% | $50.32M-1.8% | $51.22M+41.0% | $36.32M+67.1% | ||
| -$6.34M— | —— | —— | -$1.88M+78.5% | ||
| -$6.88M-154% | $12.64M-15.3% | $14.93M+140% | $6.22M— | ||
| $2.14M+1,010% | $193K-95.5% | $4.31M+157% | $1.68M+614% | ||
| $3.1M+171% | -$4.37M— | —— | —— | ||
| —— | —— | —— | $8.5M+36.8% | ||
| —— | —— | —— | —— | ||
| —— | —— | -$635K— | —— | ||
| —— | $555K— | $0— | $0— | ||
| -$1.28M+1.1% | -$1.29M— | —— | -$608K+28.6% | ||
| $64.35M-0.8% | $64.87M— | —— | -$41.66M-119% | ||
| $36.02M+27.2% | $28.33M+108% | $13.62M+142% | $5.63M+61.7% | ||
| $188.71M-8.3% | $205.73M+8.8% | $189.08M+40.4% | $134.69M— | ||
| —— | $0— | $0— | —— | ||
| $45K+150% | $18K+38.5% | $13K-93.3% | $195K— | ||
| —— | $0— | $0— | —— | ||
| $2.11M— | $0— | $0— | —— | ||
| —— | —— | -$16.18M+90.3% | -$166.55M-150% | ||
| $2.21M+9.4% | $2.02M+650% | $269K-67.7% | $833K— | ||
| $115K+18.6% | $97K-31.7% | $142K+16.4% | $122K+1,425% | ||
| $11.66M+33.0% | $8.76M+70.7% | $5.13M+204% | $1.69M+116% | ||
| -$7.06M— | —— | -$2.3M— | —— | ||
| —— | —— | —— | -$206.69M-158% | ||
| $4.22M-36.9% | $6.69M+21.7% | $5.49M+301% | $1.37M— | ||
| —— | $555K— | $0— | —— | ||
| —— | —— | —— | $8.5M+36.8% | ||
| -$1.28M+1.1% | -$1.29M— | —— | -$608K+28.6% | ||
| -$1.37M-3.8% | -$1.32M— | —— | -$991K-6.4% | ||
| —— | —— | —— | -$963K-142% | ||
| $391K+249% | -$262K— | —— | -$618K— | ||
| —— | —— | —— | —— | ||
| —— | —— | -$635K— | —— | ||
| —— | $0— | $0— | —— | ||
| —— | $0— | $0— | —— | ||
| $45K+150% | $18K+38.5% | $13K-93.3% | $195K— | ||
| $115K+18.6% | $97K-31.7% | $142K+16.4% | $122K+1,425% | ||
| $2.42M-19.0% | $2.98M+10.0% | $2.71M+8.7% | $2.49M+7.8% | ||
| —— | —— | —— | $1.4M— | ||
| -$1.28M+1.1% | -$1.29M— | —— | -$608K+28.6% | ||
| —— | $218K— | —— | $0— | ||
| $28.33M-22.5% | $36.54M— | —— | -$47.29M-110% | ||
| $28.33M-22.5% | $36.54M— | —— | -$47.29M-110% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Castle Biosciences generate?
- Castle Biosciences (CSTL) generated $48.3M in operating cash flow over the trailing twelve months.
- What is Castle Biosciences's free cash flow?
- After $43.7M of capital expenditures, Castle Biosciences's free cash flow was $4.5M over the trailing twelve months, down 89.2% year over year.
- Where does Castle Biosciences's cash flow data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
